Celsius vs Coca-Cola Consolidated
CELH and COKE side by side, both in beverages. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CELH and COKE compare
Coca-Cola Consolidated is the larger company, worth 1.9 times as much as Celsius ($14.0B against $7.4B).
Celsius grew revenue faster over the last twelve months (82.9% versus 10.7% for Coca-Cola Consolidated).
Coca-Cola Consolidated keeps more of each dollar of sales as profit, with a net margin of 7.2% compared with 4.2% at Celsius.
Coca-Cola Consolidated pays a dividend yielding 0.48%; Celsius does not pay one.
Coca-Cola Consolidated scores higher on the StockData Score (15 against 9 for Celsius), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CELH | COKE |
|---|---|---|
| Size and price | ||
| Market cap | $7.4B | $14.0B |
| Share price | $29.12 | $210.30 |
| Change, 1 year | −52.6% | 64.3% |
| Change, 5 years | −19.2% | 385% |
| Beta (5Y) | 1.54 | 0.53 |
| Employees | 1,497 | 17K |
| StockData Score | ||
| Total score | 9 | 15 (better) |
| Valuation score | 1 | 2 (better) |
| Growth score | 2 (better) | 1 |
| Performance score | 4 | 6 (better) |
| Health score | 2 | 3 (better) |
| Dividend score | 0 | 3 (better) |
| Valuation | ||
| P/E | 127× | – |
| P/S | 2.4× | 1.8× (better) |
| P/B | 6.1× | – |
| EV/EBITDA | 37.6× | 13.6× (better) |
| P/FCF | 15.9× (better) | 21.7× |
| FCF yield | 6.3% (better) | 4.6% |
| Fair value | $14.88 | $229.58 |
| Margin of safety | −95.7% | 8.4% (better) |
| Growth | ||
| Revenue growth (TTM) | 82.9% (better) | 10.7% |
| Revenue growth, 5Y average | 80.7% (better) | 7.6% |
| Net income growth (TTM) | −2.0% (better) | −6.1% |
| EPS growth (TTM) | −39.5% | – |
| EPS growth, 5Y average | 46.8% | – |
| Profitability | ||
| Gross margin | 48.8% (better) | 39.1% |
| Operating margin | 5.3% | 13.0% (better) |
| Net margin | 4.2% | 7.2% (better) |
| FCF margin | 15.2% (better) | 8.4% |
| Return on equity | 10.5% | 97.3% (better) |
| Return on invested capital | 10.6% | 39.8% (better) |
| Financial health | ||
| Debt / equity | 0.56 | – |
| Net debt / EBITDA | 0.22 (better) | 1.95 |
| Interest coverage | 3.0× | – |
| Current ratio | 1.80 (better) | 1.21 |
| Altman Z-score | 2.97 | 4.07 (better) |
| Piotroski F-score | 5 (better) | 3 |
| Dividends and buybacks | ||
| Dividend yield | – | 0.48% |
| Payout ratio | – | 13.9% |
| Buyback yield | 0.17% | – |
| Shareholder yield | 0.17% | 0.48% (better) |
| Ownership | ||
| Held by institutions | 65.9% | 62.3% |
| Held by insiders | 2.0% | 15.9% |
| Insider net buying, 12 months | $3.1M (better) | −$2.4B |
| Superinvestors holding | 1 | – |
| Short interest, % of float | 12.5% | 4.9% |
Go deeper
- CELH stock overview
- CELH income statement
- CELH valuation and score
- COKE stock overview
- COKE income statement
- COKE valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.